Skip to main content
Top
Published in: Familial Cancer 3/2010

01-09-2010

Location in the large bowel influences the APC mutations observed in FAP adenomas

Authors: O. C. Will, S. J. Leedham, G. Elia, R. K. S. Phillips, S. K. Clark, I. P. M. Tomlinson

Published in: Familial Cancer | Issue 3/2010

Login to get access

Abstract

The right colon differs from the left, in embryological origin, luminal environment, and function. In both sporadic colorectal cancer and Familial Adenomatous Polyposis (FAP), polyp density and cancer susceptibility vary markedly by colonic site. Adenomas in FAP have a different mutational spectrum in small intestine versus colon. This study aimed to investigate whether colonic location also influences the APC mutation spectrum in FAP. 127 1–2 mm mildly dysplastic adenomas from 5 patients with a codon 1309 germline mutation, and 41 from 3 patients with mutations proximal to codon 1265, were analysed to assess the frequency of loss of heterozygosity (LOH). We chose polyps from different locations in the colon. Immunohistochemistry for beta-catenin, caspase-3 and Ki-67 was performed to assess Wnt pathway activation, apoptosis and proliferation. In polyps from patients with a 1309 mutation, the frequency of LOH showed a gradient from rectum (highest) to caecum/ascending colon (lowest), but this was not present in patients with proximal germline APC mutations. Crypt-by-crypt analysis confirmed the LOH findings from whole polyps. Beta-catenin and caspase-3 expression showed no significant variation by colonic region, but Ki-67 expression decreased from ascending colon to rectum in tumours and normal tissue. Colonic site alters the mutational spectrum of APC, and crypt cell proliferation. The higher frequency of LOH in rectal polyps from patients with codon 1309 mutations may help to explain their increased polyp burden at this site compared with patients who have other germline APC mutations.
Literature
1.
go back to reference Ficari F, Cama A, Valanzano R et al (2000) APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis. Br J Cancer 82(2):348–353CrossRefPubMed Ficari F, Cama A, Valanzano R et al (2000) APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis. Br J Cancer 82(2):348–353CrossRefPubMed
2.
go back to reference Keating J, Pater P, Lolohea S, Wickremesekera K (2003) The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry? N Z Med J 116(1174):U437PubMed Keating J, Pater P, Lolohea S, Wickremesekera K (2003) The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry? N Z Med J 116(1174):U437PubMed
3.
go back to reference van Gorkom BA, Cats A, van der Meer R et al (1997) Effects of hemicolectomy on bile acid metabolism in relation to colon carcinogenesis in man. Eur J Clin Invest 27(7):589–594CrossRefPubMed van Gorkom BA, Cats A, van der Meer R et al (1997) Effects of hemicolectomy on bile acid metabolism in relation to colon carcinogenesis in man. Eur J Clin Invest 27(7):589–594CrossRefPubMed
4.
go back to reference Oh SW, Kim YH, Choi YS et al (2008) The comparison of the risk factors and clinical manifestations of proximal and distal colorectal cancer. Dis Colon Rectum 51(1):56–61CrossRefPubMed Oh SW, Kim YH, Choi YS et al (2008) The comparison of the risk factors and clinical manifestations of proximal and distal colorectal cancer. Dis Colon Rectum 51(1):56–61CrossRefPubMed
5.
go back to reference Nusko G, Mansmann U, Altendorf-Hofmann A, Groitl H, Wittekind C, Hahn EG (1997) Risk of invasive carcinoma in colorectal adenomas assessed by size and site. Int J Colorectal Dis 12(5):267–271CrossRefPubMed Nusko G, Mansmann U, Altendorf-Hofmann A, Groitl H, Wittekind C, Hahn EG (1997) Risk of invasive carcinoma in colorectal adenomas assessed by size and site. Int J Colorectal Dis 12(5):267–271CrossRefPubMed
6.
go back to reference Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP (1999) Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 23(7):721–726CrossRefPubMed Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP (1999) Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 23(7):721–726CrossRefPubMed
7.
go back to reference Sjo OH, Lunde OC, Nygaard K, Sandvik L, Nesbakken A (2008) Tumour location is a prognostic factor for survival in colonic cancer patients. Colorectal Dis 10(1):33–40PubMed Sjo OH, Lunde OC, Nygaard K, Sandvik L, Nesbakken A (2008) Tumour location is a prognostic factor for survival in colonic cancer patients. Colorectal Dis 10(1):33–40PubMed
8.
go back to reference Anti M, Armuzzi A, Morini S et al (2001) Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas. Gut 48(2):238–246CrossRefPubMed Anti M, Armuzzi A, Morini S et al (2001) Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas. Gut 48(2):238–246CrossRefPubMed
9.
go back to reference Liu LU, Holt PR, Krivosheyev V, Moss SF (1999) Human right and left colon differ in epithelial cell apoptosis and in expression of Bak, a pro-apoptotic Bcl-2 homologue. Gut 45(1):45–50CrossRefPubMed Liu LU, Holt PR, Krivosheyev V, Moss SF (1999) Human right and left colon differ in epithelial cell apoptosis and in expression of Bak, a pro-apoptotic Bcl-2 homologue. Gut 45(1):45–50CrossRefPubMed
10.
go back to reference Kushiyama Y, Fukuda R, Suetsugu H et al (2000) Site-dependent production of transforming growth factor beta1 in colonic mucosa: its possible role in tumorigenesis of the colon. J Lab Clin Med 136(3):201–208CrossRefPubMed Kushiyama Y, Fukuda R, Suetsugu H et al (2000) Site-dependent production of transforming growth factor beta1 in colonic mucosa: its possible role in tumorigenesis of the colon. J Lab Clin Med 136(3):201–208CrossRefPubMed
11.
go back to reference Mills S, Mathers J, Chapman PD, Burn J, Gunn A (2001) Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut 48(1):41–46CrossRefPubMed Mills S, Mathers J, Chapman PD, Burn J, Gunn A (2001) Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut 48(1):41–46CrossRefPubMed
12.
go back to reference Baker K, Zhang Y, Jin C, Jass JR (2004) Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J Clin Pathol 57(10):1089–1093CrossRefPubMed Baker K, Zhang Y, Jin C, Jass JR (2004) Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J Clin Pathol 57(10):1089–1093CrossRefPubMed
13.
go back to reference Deng G, Kakar S, Tanaka H et al (2008) Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. Eur J Cancer 44(9):1290–1301CrossRefPubMed Deng G, Kakar S, Tanaka H et al (2008) Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. Eur J Cancer 44(9):1290–1301CrossRefPubMed
14.
go back to reference Lüchtenborg M, Weijenberg MP, Roemen GM et al (2004) APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. Carcinogenesis 25(7):1219–1226CrossRefPubMed Lüchtenborg M, Weijenberg MP, Roemen GM et al (2004) APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. Carcinogenesis 25(7):1219–1226CrossRefPubMed
15.
go back to reference Albuquerque C, Breukel C, van der Luijt R et al (2002) The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 11(13):1549–1560CrossRefPubMed Albuquerque C, Breukel C, van der Luijt R et al (2002) The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 11(13):1549–1560CrossRefPubMed
16.
go back to reference Crabtree M, Sieber OM, Lipton L et al (2003) Refining the relation between ‘first hits’ and ‘second hits’ at the APC locus: the ‘loose fit’ model and evidence for differences in somatic mutation spectra among patients. Oncogene 22(27):4257–4265CrossRefPubMed Crabtree M, Sieber OM, Lipton L et al (2003) Refining the relation between ‘first hits’ and ‘second hits’ at the APC locus: the ‘loose fit’ model and evidence for differences in somatic mutation spectra among patients. Oncogene 22(27):4257–4265CrossRefPubMed
17.
go back to reference Lamlum H, Ilyas M, Rowan A et al (1999) The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson’s ‘two-hit’ hypothesis. Nat Med 5(9):1071–1075CrossRefPubMed Lamlum H, Ilyas M, Rowan A et al (1999) The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson’s ‘two-hit’ hypothesis. Nat Med 5(9):1071–1075CrossRefPubMed
18.
go back to reference Groves C, Lamlum H, Crabtree M et al (2002) Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160(6):2055–2061PubMed Groves C, Lamlum H, Crabtree M et al (2002) Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160(6):2055–2061PubMed
19.
go back to reference Will OC, Robinson J, Gunther T, Phillips RK, Clark SK, Tomlinson I (2008) APC mutation spectrum in ileoanal pouch polyps resembles that of colorectal polyps. Br J Surg 95(6):765–769CrossRefPubMed Will OC, Robinson J, Gunther T, Phillips RK, Clark SK, Tomlinson I (2008) APC mutation spectrum in ileoanal pouch polyps resembles that of colorectal polyps. Br J Surg 95(6):765–769CrossRefPubMed
20.
go back to reference Leedham S, Wright N (2008) Human tumour clonality assessment-flawed but necessary. J Pathol 215(4):351–354CrossRefPubMed Leedham S, Wright N (2008) Human tumour clonality assessment-flawed but necessary. J Pathol 215(4):351–354CrossRefPubMed
Metadata
Title
Location in the large bowel influences the APC mutations observed in FAP adenomas
Authors
O. C. Will
S. J. Leedham
G. Elia
R. K. S. Phillips
S. K. Clark
I. P. M. Tomlinson
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2010
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-010-9332-y

Other articles of this Issue 3/2010

Familial Cancer 3/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine